STOCK TITAN

ZVRA (NASDAQ: ZVRA) investor files notice to sell 4,080 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of ZVRA common stock filed a Rule 144 notice to sell 4,080 shares, with an aggregate market value of $36,148.80. The planned sale is through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 01/30/2026.

The shares come from restricted stock units acquired from the issuer on 01/30/2026 in the same amount of 4,080 units. The form notes that there are 56,297,535 ZVRA common shares outstanding at the time of this notice.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ZVRA Form 144 filing disclose?

The Form 144 shows a ZVRA shareholder intends to sell 4,080 common shares under Rule 144. These shares have an aggregate market value of $36,148.80 and will be sold on NASDAQ through Morgan Stanley Smith Barney LLC, subject to market conditions and Rule 144 requirements.

How many ZVRA shares are involved in this Rule 144 sale?

The notice covers 4,080 ZVRA common shares. The filing lists an aggregate market value of $36,148.80 for these shares. It also states that 56,297,535 ZVRA common shares are outstanding, providing context for the size of the planned sale.

What is the source of the ZVRA shares being sold under Form 144?

The shares come from restricted stock units in ZVRA common stock. The Form 144 states that 4,080 units were acquired from the issuer as restricted stock units on 01/30/2026, matching the number of shares now listed for potential sale under Rule 144.

Which broker and exchange are used in the ZVRA Form 144 sale?

The filing names Morgan Stanley Smith Barney LLC Executive Financial Services as the broker for the planned ZVRA trade. The shares are to be sold on the NASDAQ exchange, aligning with the listing venue shown in the Form 144 securities information table.

When is the ZVRA Rule 144 sale expected to occur?

The Form 144 lists an approximate sale date of 01/30/2026 for the 4,080 ZVRA shares. This date reflects when the holder expects to begin selling the shares on NASDAQ through Morgan Stanley Smith Barney LLC, subject to Rule 144 conditions.

How does the planned ZVRA sale compare with total shares outstanding?

The Form 144 indicates there are 56,297,535 ZVRA common shares outstanding. The planned sale of 4,080 shares is presented against this outstanding figure in the table, giving investors a sense of the relative size of the transaction.
Zevra Therapeutics Inc

NASDAQ:ZVRA

ZVRA Rankings

ZVRA Latest News

ZVRA Latest SEC Filings

ZVRA Stock Data

498.80M
54.85M
0.69%
65.12%
12.28%
Biotechnology
Pharmaceutical Preparations
Link
United States
CELEBRATION